Soy phosphatidylserine approved for cognitive health claims in Australia and New Zealand

Photo © iStockphoto.com/adventtr

Following the notification of a self-substantiated food-health relationship, the Food Standards Australia New Zealand (FSANZ) authority has accepted and listed a claim for soy phosphatidylserine from the branded ingredient Sharp-PS (from IFF Health; New York City, NY) for the “Maintenance and/or improvement of cognitive function and brain health.” This new claim allows Australian and New Zealand brands the option to add Sharp-PS to their products, and opens up the opportunity to launch function food products that target cognitive health. 

“The ability to include brain health and cognitive claims with Sharp-PS is exciting and creates a unique opportunity for IFF and for better-for-you food and beverage makers in Australia and New Zealand,” said Pinni Raveh, sales manager for IFF Health, in a press release.

“The benefits of PS consumption have been demonstrated in numerous clinical and pre-clinical studies, leading FSANZ to link its consumption to these benefits,” added Itay Shafat, PhD, product manager for Cognitive Line, IFF Health, in a press release. “Phosphatidylserine is ideal for inclusion into food and beverage matrices, as it has no taste or smell, and does not affect mouthfeel.”